APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L108. A total of 51 filers reported holding APTEVO THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $37,000 | -95.5% | 63,244 | -93.2% | 0.00% | – |
| Q2 2019 | $827,000 | -30.3% | 932,836 | -29.2% | 0.00% | – |
| Q1 2019 | $1,187,000 | -35.2% | 1,318,365 | -8.6% | 0.00% | -100.0% |
| Q4 2018 | $1,831,000 | -74.7% | 1,442,049 | +1.2% | 0.00% | -66.7% |
| Q3 2018 | $7,242,000 | +7.4% | 1,425,567 | +5.5% | 0.00% | 0.0% |
| Q2 2018 | $6,745,000 | +69.1% | 1,351,656 | +10.8% | 0.00% | +50.0% |
| Q1 2018 | $3,989,000 | -14.2% | 1,219,852 | +11.2% | 0.00% | 0.0% |
| Q4 2017 | $4,650,000 | +127.3% | 1,096,616 | +22.8% | 0.00% | +100.0% |
| Q3 2017 | $2,046,000 | -6.4% | 893,338 | -15.5% | 0.00% | 0.0% |
| Q2 2017 | $2,187,000 | +8.5% | 1,056,729 | +8.0% | 0.00% | 0.0% |
| Q1 2017 | $2,016,000 | -15.6% | 978,620 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $2,388,000 | -13.1% | 978,620 | -8.9% | 0.00% | 0.0% |
| Q3 2016 | $2,749,000 | – | 1,073,956 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 1,021,836 | $1,298,000 | 0.18% |
| HighVista Strategies LLC | 79,568 | $101,000 | 0.09% |
| ATLAS CAPITAL ADVISORS LLC | 49,045 | $62,287,000 | 0.02% |
| Spark Investment Management LLC | 135,600 | $172,000 | 0.01% |
| Park West Asset Management LLC | 165,520 | $210,000 | 0.01% |
| CSS LLC/IL | 86,727 | $110,000 | 0.01% |
| Meridian Wealth Advisors, LLC | 5,000 | $6,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 462,824 | $587,000 | 0.00% |
| OXFORD ASSET MANAGEMENT LLP | 101,014 | $128,000 | 0.00% |
| SFMG, LLC | 15,544 | $20,000 | 0.00% |